The University of Tennessee Graduate School of Medicine, Knoxville



The Department of Surgery

John L. Bell, MD, FACS

Professor
Division of Surgical Oncology

Clinical Focus

Breast Cancer, General Oncologic Surgery, Outreach/Education, Screening

Education

Medical School
University of Alabama in Birmingham School of Medicine, Birmingham, AL

Internship
General Surgery, University of Alabama in Birmingham, Birmingham, AL

Residency
General Surgery, University of Alabama in Birmingham, Birmingham, AL

Fellowship
Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX

Certifications

American Board of Surgery

Professional Affiliations

Southern Surgical Association
Society of Surgical Oncology
Southeastern Surgical Congress
American Society of Breast Surgeons
National Consortium of Breast Centers
American Society of Breast Disease
American Society of Clinical Oncology
American College of Surgeons
American Cancer Society
American College of Physician Executives
American Medical Association
Association for Academic Surgery
Association of Cancer Executives
Knoxville Academy of Medicine
Medical Association of the State of Alabama
Tennessee Medical Association

Current Publications

Orucevic A, Bell JL, King M, McNabb AP, Heidel RE.
Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data. Breast (Edinburgh, Scotland). 2019 May 10;46:116-125.

Roberson PNE, Miller M, Lloyd J, Bell C, Heidel ER, Bell J.
Economic disparities in Appalachia linked to risk factors for long-term health for estrogen positive breast cancer patients. Cancer Treatment and Research Communications. 2019;19:100128. Epub 2019 Mar 14.

Roberson PNE, Southerland A, Mitchel H, Lloyd J, Heidel RE, Bell JL.
Factors predicting medication prescription adherence in Appalachian breast cancer patients. The Breast Journal. 2019 Feb 13. [Epub ahead of print]

Orucevic A, Bell JL, McNabb AP, Heidel RE.
Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data. Breast Cancer Research and Treatment. 2017 May;163(1):51-61. Epub 2017 Feb 27.

Bhat S, Orucevic A, Woody C, Heidel RE, Bell JL.
Evolving trends and influencing factors in mastectomy decisions. The American Surgeon. 2017 Mar 1;83(3):233-238.

Orucevic A, Heidel RE, Bell JL.
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis. Breast Cancer Research and Treatment. 2016 Jun;157(3):427-35. Epub 2016 May 20.

Current Presentations

Cochrane K, Heidel RE, Bell JL, Orucevic A. Adenosquamous carcinoma of the breast, an uncommon diagnosis with poor prognosis – lessons learned from a twelve year analysis of the National Cancer Data Base. Presented at San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX.

Orucevic A, Heidel R, Bell JL. Using the National Cancer Data Base (NCDB) and Oncotype DX data to predict adjuvant therapy effect on overall survival (OS) of N0 & N1 breast cancer patients. Presented at American Society of Clinical Oncology Annual Meeting; 2018 Jun 1-5; Chicago, IL.

Pospiech EA, Bell JL, King M. Mobile mammography and digital technology in a large-scale, Appalachian screening population. Presented at Southeastern Surgical Congress; 2018 Feb 10-13; Tampa, FL.

Orucevic A, Heidel RE, Bell JL. Outcomes of patients with invasive breast cancer (IBC) refusing standard cancer treatments: 10-year analysis of the National Cancer Data Base (NCDB). Presented at San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX.

Rose CE, Heidel RE, Bell JL, Orucevic A. Primary neuroendocrine carcinoma of the breast – lessons learned from a ten year analysis of the National Cancer Data Base (NCDB). Presented at San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX.

Ward AJ, Jerkins L, Bell JL. Finding common ground: Aligning institutional and survivorship steering committee (SSC) goals. Presented at Cancer Survivorship Symposium; 2017 Jan 27-28; San Diego, CA.

Bhat S, Heidel R, Bell J, Orucevic A. Influencing factors and evolving trends for contralateral prophylactic mastectomy in breast cancer patients. Presented at 2nd World Congress on Breast Cancer; 2016 Sep 19-21; Phoenix, AZ.

McNeil M, Heidel R, Bell JL, Orucevic A. Factors influencing decisions of breast cancer patients to follow-up on recommendations for genetic counselling - The University of Tennessee Medical Center experience. Presented at 2nd World Congress on Breast Cancer (Invited Lecture); 2016 Sep 19-21; Phoenix, AZ.

Top



Support The University of Tennessee Graduate School of Medicine

The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290

Copyright © 2019